Two members of NCCN’s Global Policy team are presenting original research abstracts on National Cancer Control Plans and Tailoring Guidelines for Regional Realities as part of the three-day World Cancer Congress in Hong Kong.

With billions of dollars in federal biomedical research support in question, universities should look to build collaborations with industry, which today provides only about 3 to 8 percent of research funding for the 243 universities ranked as the best in the U.S. for translational science by the Cure Innovation Index. A new Cure analysis finds universities engage industry through four distinct pathways: scientific collaboration, industry-sponsored clinical research, small-business partnerships, and entrepreneurial training. On the first two, the expected pattern holds and top-ranked universities lead. On the second two, it reverses and lower-ranked universities outperform the top-ranked.

The historical carbon emissions of major oil, gas, coal, and cement producers will contribute to global warming for many centuries, per simulations under a range of future emissions scenarios.

GBIF marks its 25th anniversary having grown from 21 founding countries to a network spanning 70 participating countries, 42 other associate participants and crossing 3.8 billion biodiversity records. A new overview, published in the Biodiversity Data Journal, traces GBIF's evolution from natural history collections to DNA and survey data, its role underpinning 15,000+ research papers and major policy frameworks, and the persistent challenges, including geographic and taxonomic data gaps, that remain as the organisation looks toward its next 25 years.